Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Cash flows provided by (disbursed for) operating activities:
Net income	$ 228,394	$ 206,187	$ 152,318
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on foreign currency exchange rates	8,371
Restructuring and related impairment charges			23,627
Depreciation and amortization	141,957	136,559	141,384
Stock-based compensation	25,822	21,343	12,855
Impairment of assets	3,897
(Gain) loss reclassified from accumulated other comprehensive income to net income	(5,813)	(2,115)	2,675
Deferred income taxes	1,446	6,777	(31,154)
Provision for inventory obsolescence	3,679	16	3,601
Allowances for accounts receivable	8,518	6,071	11,344
Pension and postretirement plans expense	629	1,306	109,823
Other	(5,016)	2,473	(924)
Qualified pension plan contributions	(1,000)		(7,600)
Changes in operating assets and liabilities:
Accounts receivable, net	(55,420)	(10,600)	(25,021)
Inventories, net	(37,396)	(9,767)	(1,771)
Hedging activities, net	(224)	(4,967)	15,829
Accounts payable	82,125	38,076	(5,772)
Other assets and accrued liabilities	(39,080)	(46,749)	53,250
Net cash provided by operating activities	360,889	344,610	454,464
Cash flows provided by (disbursed for) investing activities:
Purchases of property, plant and equipment	(169,071)	(135,964)	(97,929)
Repurchase of independent distributor territories	(8,163)	(4,585)	(3,114)
Cash paid at issuance of notes receivable	(11,860)	(12,135)	(10,660)
Principal payments from notes receivable	38,852	31,996	32,153
Acquisition of trademark		(10,200)
Proceeds from sales of property, plant and equipment	7,681	2,995	5,368
Purchase of leased warehouses		(64,689)
Investment in unconsolidated affiliate	(9,000)
Other investing activities	473	1,144	190
Net cash disbursed for investing activities	(151,088)	(191,438)	(73,992)
Cash flows provided by (disbursed for) financing activities:
Dividends paid, including dividends on share-based payment awards	(186,501)	(175,903)	(167,270)
Contingent consideration			(4,700)
Payments for debt issuance costs	(282)	(6,022)	(206)
Stock repurchases	(34,586)	(9,510)	(783)
Change in bank overdrafts	799	261	3,134
Proceeds from debt borrowings	330,000	497,570	484,900
Debt obligation payments	(330,000)	(579,428)	(392,400)
Payments on financing leases	(1,597)	(1,745)	(6,715)
Net cash disbursed for financing activities	(222,167)	(274,777)	(84,040)
Effect of exchange rates on cash	(8,371)
Net (decrease) increase in cash and cash equivalents	(12,366)	(121,605)	296,432
Cash and cash equivalents at beginning of period	185,871	307,476	11,044
Cash and cash equivalents at end of period	165,134	185,871	307,476
Schedule of non-cash investing and financing activities:
Right-of-use assets obtained in exchange for new financing lease liabilities		37	79
Right-of-use assets obtained in exchange for new operating lease liabilities	33,559	55,869	16,022
Distributor routes sold with deferred gains, net	280	241	207
Purchase of property, plant and equipment included in accounts payable	6,716	9,124	4,662
Cash paid during the period for:
Interest	27,590	52,620	35,920
Income taxes paid, net of refunds of $9,797, $305 and $917, respectively	53,044	69,401	68,758
Executive Deferred Compensation Plan
Schedule of non-cash investing and financing activities:
Issuance of executive deferred compensation plan common stock	46	177	39
Distributor Notes Receivable
Schedule of non-cash investing and financing activities:
Issuance of notes receivable on new distribution territories, net	$ 22,446	$ 21,008	$ 25,029